Literature DB >> 18512819

Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index.

Michelle Petri1, Nuntana Kasitanon, Shin-Seok Lee, Kimberly Link, Laurence Magder, Sang-Cheol Bae, John G Hanly, David A Isenberg, Ola Nived, Gunnar Sturfelt, Ronald van Vollenhoven, Daniel J Wallace, Graciela S Alarcón, Dwomoa Adu, Carmen Avila-Casado, Sasha R Bernatsky, Ian N Bruce, Ann E Clarke, Gabriel Contreras, Derek M Fine, Dafna D Gladman, Caroline Gordon, Kenneth C Kalunian, Michael P Madaio, Brad H Rovin, Jorge Sanchez-Guerrero, Kristjan Steinsson, Cynthia Aranow, James E Balow, Jill P Buyon, Ellen M Ginzler, Munther A Khamashta, Murray B Urowitz, Mary Anne Dooley, Joan T Merrill, Rosalind Ramsey-Goldman, Josef Font, James Tumlin, Thomas Stoll, Asad Zoma.   

Abstract

OBJECTIVE: To develop a measure of renal activity in systemic lupus erythematosus and use it to develop a renal response index.
METHODS: Abstracted data from the medical records of 215 patients with lupus nephritis were sent to 8 nephrologists and 29 rheumatologists for rating. Seven nephrologists and 22 rheumatologists completed the ratings. Each physician rated each patient visit with respect to renal disease activity (none, mild, moderate, or severe). Using the most commonly selected rating for each patient as the gold standard, stepwise regression modeling was performed to identify the variables most related to renal disease activity, and these variables were then used to create an activity score. This activity score could then be applied to 2 consecutive visits to define a renal response index.
RESULTS: The renal activity score was computed as follows: proteinuria 0.5-1 gm/day (3 points), proteinuria 0.5-1 gm/day = 3 points, proteinuria >1-3 gm/day = 5 points, proteinuria >3 gm/day = 11 points, [corrected] urine red blood cell count > = 5/hpf = 3 points, [corrected] urine white blood cell count > or = 5/hpf = 1 point. [corrected] The chance-adjusted agreement between the renal response index derived from the activity score applied to the paired visits and the plurality physician response rating was 0.69 (95% confidence interval 0.59-0.79).
CONCLUSION: Ratings derived from this index for rating of renal response showed reasonable agreement with physician ratings in a pilot study. The index will require further refinement, testing, and validation. A data-driven approach to create renal activity and renal response indices will be useful in both clinical care and research settings.

Entities:  

Mesh:

Year:  2008        PMID: 18512819     DOI: 10.1002/art.23456

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

1.  Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis.

Authors:  Adnan N Kiani; Tianfu Wu; Hong Fang; Xin J Zhou; Chul W Ahn; Laurence S Magder; Chandra Mohan; Michelle Petri
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

Review 2.  Top 10 things to know about lupus activity measures.

Authors:  Aikaterini Thanou; Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

3.  Development of Biomarker Models to Predict Outcomes in Lupus Nephritis.

Authors:  Bethany J Wolf; John C Spainhour; John M Arthur; Michael G Janech; Michelle Petri; Jim C Oates
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

Review 4.  Rituximab therapy in lupus nephritis: current clinical evidence.

Authors:  Manuel Ramos-Casals; Candido Diaz-Lagares; Maria-Jose Soto-Cardenas; Pilar Brito-Zeron; María-José Cuadrado; Giovanni Sanna; Laura Bertolaccini; Munther A Khamashta
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

5.  Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis.

Authors:  Tianfu Wu; Yong Du; Jie Han; Sandeep Singh; Chun Xie; Yuyuan Guo; Xin J Zhou; Chul Ahn; Ramesh Saxena; Chandra Mohan
Journal:  Mol Cell Proteomics       Date:  2013-01-23       Impact factor: 5.911

6.  Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Rina Mina; Khalid Abulaban; Marisa S Klein-Gitelman; Barbara A Eberhard; Stacy P Ardoin; Nora Singer; Karen Onel; Lori Tucker; Kathleen O'neil; Tracey Wright; Elizabeth Brooks; Kelly Rouster-Stevens; Lawrence Jung; Lisa Imundo; Brad Rovin; David Witte; Jun Ying; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-02       Impact factor: 4.794

7.  Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.

Authors:  Ahmed Mohamed Mahmoud Badr; Yomna Farag; Maie Abdelshafy; Nermine Magdi Riad
Journal:  Clin Rheumatol       Date:  2017-09-09       Impact factor: 2.980

Review 8.  Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research.

Authors:  Jamal Mikdashi; Ola Nived
Journal:  Arthritis Res Ther       Date:  2015-07-20       Impact factor: 5.156

9.  Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.

Authors:  Shuhong Chi; Yunxia Yu; Juan Shi; Yurong Zhang; Jijuan Yang; Lijuan Yang; Xiaoming Liu
Journal:  Dis Markers       Date:  2015-10-13       Impact factor: 3.434

10.  Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.

Authors:  Waleed Hassan; Eman Behiry; Marwa Mahgoub
Journal:  Arch Rheumatol       Date:  2020-06-26       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.